Fortis Group Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Fortis Group Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$678	Hold	20	–	–	﹤0.01%	570
2026 Q1	$602	Hold	20	–	–	﹤0.01%	539
2025 Q4	$624	Hold	20	–	–	﹤0.01%	531
2025 Q3	$404	Hold	20	–	–	﹤0.01%	498
2025 Q2	$335	Hold	20	–	–	﹤0.01%	494
2025 Q1	$307	Hold	20	–	–	﹤0.01%	466
2024 Q4	$441	Hold	20	–	–	﹤0.01%	469
2024 Q3	$360	Hold	20	–	–	﹤0.01%	467
2024 Q2	$325	Hold	20	–	–	﹤0.01%	471
2024 Q1	$282	Sell	20 -20	-50%	-$252	﹤0.01%	486
2023 Q4	$418	Buy	40 +20	+100%	+$187	﹤0.01%	427
2023 Q3	$204	Buy	+20	New	+$186	﹤0.01%	427
2020 Q3	$0	Buy	+20	New	+$212	﹤0.01%	476

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Fortis Group Advisors's TEVA Position: Q2 2026 in Review

Fortis Group Advisors held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 20 shares worth $678. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Fortis Group Advisors first reported a position in TEVA in Q3 2020 and has held it in 13 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Fortis Group Advisors held 20 shares of Teva Pharmaceutical Industries Limited worth $678 as of Q2 2026.
Fortis Group Advisors left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Fortis Group Advisors's portfolio in Q2 2026, its #570 holding.
Fortis Group Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q3 2020 and has held it in 13 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.